Rikshospitalet- Radiumhospitalet HF
Montebello, Oslo, 0310, Norway
NCT Number: NCT00658229
The purpose of this study is to determine the effectiveness of a four months strength training program on physical and psychological health in patients with prostate cancer during androgen deprivation therapy. It is hypothesized a beneficial effect of the intervention on physical and psychological health in patients with prostate cancer treated with androgen deprivation.
Looking for future studies?
Notify MeUp to 75 year
Male
Interventional
Phase 3
Montebello, Oslo, 0310, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After 5-10 months on androgen deprivation therapy the patients in the intervention group go through a four months strength training intervention. The patients will perform three strength-training sessions per week, two under supervision of a sport instructor. Each session will consists of one-three sets of nine strength-training exercises, performed at an intensity of 6 or 10 repetitions of maximum (6-10 RM).
Other names: Exercise, Physical activity
Time frame: before ADT, before and after the intervention
Time frame: before ADT, before and after the intervention
Oslo University Hospital
Other
Physical Exercise for Patients With Prostate Cancer During Androgen Deprivation Therapy - A Randomized Trial
Acronym: PEPC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05801965
Behavior, Cancer
Reykjavik, Iceland
View Trial DetailsNCT05131815
Astrocytoma, Behavior
Los Angeles, California, United States
View Trial DetailsNCT04896580
Behavior, Breast Cancer
Los Angeles, California, United States
View Trial DetailsNCT05064670
Behavior, Breast Cancer
Stockholm, Sweden
View Trial Details